Multiple Sclerosis, Disease-Modifying Therapies, and Infections

BACKGROUND AND OBJECTIVES: The use of highly effective multiple sclerosis (MS) disease-modifying therapies (DMTs) is rapidly increasing. Yet, little is known about their real-world risks of infections. The goals of this study were to assess the comparative risk of outpatient and serious infections a...

Descripción completa

Detalles Bibliográficos
Autores principales: Langer-Gould, Annette M., Smith, Jessica B., Gonzales, Edlin G., Piehl, Fredrik, Li, Bonnie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574822/
https://www.ncbi.nlm.nih.gov/pubmed/37813594
http://dx.doi.org/10.1212/NXI.0000000000200164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574822/
https://www.ncbi.nlm.nih.gov/pubmed/37813594
http://dx.doi.org/10.1212/NXI.0000000000200164

Ejemplares similares